visit|article-6476135|News-nav-hcat|2 – The Advocate

 

The Advocate

visit|article-6476135|News-nav-hcat|2
The Advocate
Stamford-based Purdue Pharma is collaborating with Eisai to commercialize an insomnia drug candidate, sharing clinical development and marketing costs in exchange for royalty rights in some markets. The companies did not disclose financial terms of the …
Eisai and Purdue Pharma collaborate on lemborexantThe Pharma Letter (registration)
Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Satellite PR News (press release)

all 5 news articles »

View full post on insomnia – Google News